Here, we demonstrated that CCL21/CCR7 signaling in TAMs is important to drive their tumor-supportive polarization in the TME and promote tumor growth and should therefore be considered as a potential new therapeutic target that could be combined with approaches to target other important regulatory pathways such as CSF-1 or Slit2. Here, CSF1 is linked to neoplasm.